Ilya Folitar

Senior Global Program Safety Team Lead and Radiopharmaceutical Safety Lead Novartis

Seminars

Wednesday 2nd December 2026
The RLT Safety Playbook: Advancing Safety Assessment and Long-Term Risk Management for Therapeutic Radiopharmaceutical Development
11:30 am
  • Examining key clinical safety challenges in therapeutic radiopharmaceutical development
  • Discussing approaches to longitudinal safety monitoring and characterisation throughout the development lifecycle
  • Exploring how emerging clinical experience can inform benefit risk assessment and safety strategies for next-generation radioligand therapies
Ilya Folitar